On the DeviceTalks Weekly podcast, Dr. Janar Sathananthan, chief medical officer, Interventional Cardiology Therapies, discusses a new treatment option in the U.S. for patients with coronary artery disease who experience in-stent restenosis. Listen here: https://lnkd.in/eEYPGWRm
Boston Scientific’s Post
More Relevant Posts
-
https://lnkd.in/g2ey7MfS Article title: Clinical features and outcome of prosthetic pulmonary valve infective endocarditis Author(s): Daniel Pastor*#; Juan Carlos Castillo*; Rafael González; José López-Aguilera; Dolores Mesa; Manuel Anguita; Manuel Pan Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: Background: Infective endocarditis is a serious complication in patients with prostheses in the right ventricle outflow tract. The aim of our study is to assess clinical features in these patients. Methods: We have analyzed all cases of prosthetic pulmonary valve infective endocarditis (PPVIE) and compared them to the rest of the patients with IE. Since the year 2000, 375 cases of IE have been diagnosed in our center and nine patients had a PPVIE.: 3 patients with Melody percutaneous prostheses, 5 with a homograft (3 after a Rastelli procedure, 2 a Ross procedure), and 1 patient with a heterograft (Contegra conduit). #Endocarditis #PulmonaryValve #Prostheses #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
https://lnkd.in/gam6wXAb Article title: Efficacy and Safety of Different Energy Settings for Atrial Fibrillation Ablation using the Duty-cycled Radiofrequency Ablation Catheter (PVAC) Author(s): Stefan Lönnerholm*; Helena Malmborg; Per Blomström; Carina Blomström-Lundqvist Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: In recent years, new ablation catheters have been developed to facilitate atrial fibrillation (AF) ablation procedures, including the multi-electrode pulmonary vein ablation catheter (PVAC), capable of using different proportions of unipolar and bipolar energy. The purpose of this study was to evaluate the acute efficacy, as well as safety, when using the two different energy settings for the PVAC catheter. #AtrialFibrillation #Ablation #RadiofrequencyEnergy #DutyCycled #PVAC #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
https://lnkd.in/gUF8RStv Article title: Acute renal artery thrombosis treated with combination use of multiple interventional techniques Author(s): Naiding Zhang; Guiya Xiong; Yifeng Pan; Changming Shao; Jian Wang; Bing Chen*; Zhenjie Liu Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: Purpose: To describe the combined use of multiple interventional techniques for the treatment of acute renal artery thrombosis. Case Report: Acute renal artery thrombosis is a rare condition, which is difficult to diagnose accurately and quickly. Failure to restore renal perfusion as quickly as possible may lead to renal dysfunction. Multiple interventional techniques are used as new options to restore renal blood flow and function. Herein we present one case of acute renal artery thrombosis treated with combination use of percutaneous rheolytic thrombectomy, catheter thrombus aspiration and intra-arterial thrombolysis in a very early stage. #AcuteRenalArteryThrombosis #MultipleInterventionalTechniques #RenalPerfusion #RenalFunction #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
Excellent talk and discussion on the value of preprocedural imaging in VT ablation.
Can we improve upon past failures and predict clinical outcomes with advanced cardiac imaging? Jeffrey Winterfield addressed this question and others in our recent inHEART on the Podium webinar. To hear our guest presenters and panelists discuss this topic and the role of image-guided ablations in optimizing treatment strategies, watch the full webinar here. https://lnkd.in/dg3fT4cH #epeeps Heart Rhythm Society European Society of Cardiology Nikola Pavlović Christian Sticherling PD Dr. Arian Sultan
To view or add a comment, sign in
-
Thrombolex announces a never-before-reported significant reduction in obstruction in every single named segmental pulmonary artery from the Prospective Multicenter RESCUE Trial with the BASHIR™ Endovascular Catheter in a manuscript published in the Journal of the American College of Cardiology (JACC): Advances (online). The major reductions in obstruction in all of the segmental pulmonary arteries were based on an independent core lab data analysis of 107 patients from 18 sites in the US with acute intermediate-risk pulmonary embolism using the BASHIR™ Endovascular Catheter and small doses of tPA. The NIH-sponsored RESCUE trial also showed unsurpassed efficacy and safety in treating this patient population compared to recently published studies with other FDA-cleared devices. Learn more at https://lnkd.in/g2UmzBux Thrombolex.com #Thrombolex
To view or add a comment, sign in
-
Bridge Bio Eidosibute ( AG10) in phase III for ATTRcm is a new opction for ouers Amilos whith transtirretin. #Acoramidis #ATTRCM #PhaseIII #SOMOSAMILO www.amilo.es
Our transthyretin amyloidosis (ATTR) team is heading to ESC Heart Failure hosted by European Society of Cardiology! This year, we will be sharing updates from our ATTRibute-CM Phase 3 trial in one oral presentation and three moderated poster presentations. We will also be supporting a Satellite Symposium with leading physicians in the cardiology space. Check out our website to learn about our latest news: bridgebio.com/what-is-attr
To view or add a comment, sign in
-
https://lnkd.in/gwDeEsaM Article title: Heart Failure (HF): Recent innovations in clinical therapy and critical profiles of acute and chronic forms Author(s): Giulio Perrotta* Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: Background and objectives: Heart failure is a pathological condition characterized by the inability of the heart to pump (cardiac output) an adequate amount of blood to meet the metabolic needs of the body or, at any rate, to be able to do so only at the expense of increased filling pressures in one or more cardiac chambers and the upstream venous circulation. The research group states here the primary objective of expanding the indications contained in the ESC 2021 with the results of the last year on the subject of treatment profiles, to facilitate a better understanding of the overall clinical picture and contribute to the next edition of the guidelines. #HeartFailure #AcuteHeartFailure #BNP #NTproBNP #ESC2021 #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
https://lnkd.in/ggh8Y-vj Article title: A possible easy way to predict response to cardiac resynchronization therapy: The role of QRS Index Author(s): Giuseppe Coppola; Cristina Madaudo*; Amedeo Prezioso; Enrico Bonnì; Giuseppina Novo; Vincenzo Sucato; Gianfranco Ciaramitaro; Alfredo Ruggero Galassi; Egle Corrado Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: Background: Some studies have evaluated the role of QRS duration (QRSd) as predictor of response to Cardiac Resynchronization Therapy (CRT). However, their results are still not entirely clear. The goal of our study was to determine the correlation between the relative change in QRS narrowing index (QI) compared to clinical outcome and prognosis in patients who underwent CRT implantation. Methods: We collected clinical and echocardiographic data of 115 patients in whome a CRT device was implanted in accordance with current guidelines. QRS duration before and after CRT implantation and QI were measured. #CRTCardiacResynchronizationTherapy #HeartFailure #Responder #NonResponder #QRSIndex #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
https://lnkd.in/gJX7ATaw Article title: Isolated infundibular pulmonary stenosis. A case report Author(s): K El ouahabi*; N Erraboun; A Bouzerda; M Raissouni; I Asfalou; A Benyass; Z Lakhal; Y Moutakillah; M Ait Houssa; E Zbir Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: Introduction: Infundibular pulmonary stenosis is one of the numerous pathologic features of the right tract (from the right ventricular outflow tract to the peripheral pulmonary arteries) occurring at the infundibular level. It is usually associated with ventricular septal defect or part of tetralogy of Fallot, but rarely isolated. Methods and results: We report here a case of an adult with isolated infundibular stenosis, and discuss the relative frequency, clinical manifestations, the diagnosis methods, and the results of surgical correction of this lesion. #IsolatedInfundibularStenosis #FibromuscularHypertrophy #Infundibulectomy #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects
To view or add a comment, sign in
-
More contemporary ATTRibute-CM data elevating our understanding of ATTR-CM to be presented at #ESCHeartFailure in #Lisbon, #Portugal by global amyloidosis experts and colleagues, #SteenPoulsen, #PabloGarciaPavia, #MariannaFontana, #PeterVanDerMeer, and #LauraObici
Our transthyretin amyloidosis (ATTR) team is heading to ESC Heart Failure hosted by European Society of Cardiology! This year, we will be sharing updates from our ATTRibute-CM Phase 3 trial in one oral presentation and three moderated poster presentations. We will also be supporting a Satellite Symposium with leading physicians in the cardiology space. Check out our website to learn about our latest news: bridgebio.com/what-is-attr
To view or add a comment, sign in
1,031,783 followers